M7824 With cCRT in Unresectable Stage III Non-small Cell Lung Cancer (NSCLC)

Condition:   Non-small Cell Lung Cancer Interventions:   Drug: M7824;   Drug: Placebo;   Drug: Durvalumab;   Drug: Etoposide;   Drug: Pemetrexed;   Drug: Carboplatin;   Drug: Paclitaxel;   Drug: Cisplatin;   Radiation: Intensity Modulated Radiation Therapy (IMRT) Sponsors:   EMD Serono Research & Development Institute, Inc.;   Merck KGaA, Darmstadt, Germany Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials